Literature DB >> 22280874

Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).

Xuan Chen1, Chun Zeng, Tianyou Luo, Yu Ouyang, Fajin Lv, Reshiana Rumzan, Zhongping Wang, Qi Li, Jingjie Wang, Huanxin Hou, Fuhong Huang, Yongmei Li.   

Abstract

PURPOSE: Previous studies have detected abnormal iron deposition in the deep grey matter (DGM) of multiple sclerosis (MS). The regional specificity of the DGM iron deposition in neuromyelitis optica (NMO) is still unclear. We compared the differences in the DGM iron concentration between MS and NMO patients.
METHODS: We enrolled 42 relapsing-remitting MS (RRMS) patients, 42 NMO patients and 42 healthy controls undergoing brain conventional MRI and three-dimensional (3D)-enhanced T(2)*-weighted angiography (ESWAN) sequences. We obtained the mean phase values (MPVs) for ESWAN-filtered phase images. An analysis of covariance (ANCOVA) was used to compare MPVs among three groups. The correlations of MPVs changes with disease duration and expanded disability status scale (EDSS) were analyzed.
RESULTS: The RRMS patients had higher DGM iron concentration than did the NMO and control groups, but only the bilateral substantia nigra (SN) showed a significant statistical difference among three groups (p<0.05). In the RRMS group, the iron concentration in the bilateral head of the caudate nucleus (HCN) (left: p<0.0001; right: p=0.0134) and the dentate nucleus (DN) (p<0.05 for both) were correlated with disease duration. In the NMO group, no correlation was found between the DGM iron concentration and disease duration (p>0.05). Furthermore, no correlations were found between the DGM iron concentration and EDSS (p>0.05).
CONCLUSIONS: We confirm the iron concentration in the DGM iron content of MS patients is more than NMO patients and healthy controls in the same age range. Furthermore, the disease duration was found to be a significant contributor to patients with MS.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280874     DOI: 10.1016/j.ejrad.2012.01.003

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.

Authors:  Sanjeev Chawla; Yulin Ge; Jens Wuerfel; Shadi Asadollahi; Suyash Mohan; Friedemann Paul; Tim Sinnecker; Ilya Kister
Journal:  Mult Scler Relat Disord       Date:  2020-03-25       Impact factor: 4.339

3.  Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.

Authors:  S Chawla; I Kister; J Wuerfel; J-C Brisset; S Liu; T Sinnecker; P Dusek; E M Haacke; F Paul; Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

4.  Quantification of Phase Values of Cerebral Microbleeds in Hypertensive Patients Using ESWAN MRI.

Authors:  L F Guo; J Geng; M H Qiu; C H Mao; C Liu; L Cui
Journal:  Clin Neuroradiol       Date:  2013-01-20       Impact factor: 3.649

Review 5.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

6.  Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.

Authors:  Thomas Martin Doring; Vanessa Granado; Fernanda Rueda; Andreas Deistung; Juergen R Reichenbach; Gustavo Tukamoto; Emerson Leandro Gasparetto; Ferdinand Schweser
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

7.  MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.

Authors:  Tim Sinnecker; Sophie Schumacher; Katharina Mueller; Florence Pache; Petr Dusek; Lutz Harms; Klemens Ruprecht; Petra Nytrova; Sanjeev Chawla; Thoralf Niendorf; Ilya Kister; Friedemann Paul; Yulin Ge; Jens Wuerfel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-22

8.  Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.

Authors:  Adam Pudlac; Andrea Burgetova; Petr Dusek; Petra Nytrova; Manuela Vaneckova; Dana Horakova; Jan Krasensky; Lukas Lambert
Journal:  Biomed Res Int       Date:  2020-05-19       Impact factor: 3.411

9.  Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.

Authors:  Jinjing Yang; Xiaohu Li; Renmin Yang; Xuen Yu; Changliang Yu; Yinfeng Qian; Yongqiang Yu
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Optic radiations are thinner and show signs of iron deposition in patients with long-standing remitting-relapsing multiple sclerosis: an enhanced T2*-weighted angiography imaging study.

Authors:  Chun Zeng; Silin Du; Yongliang Han; Jialiang Fu; Qi Luo; Yayun Xiang; Xiaoya Chen; Tianyou Luo; Yongmei Li; Yineng Zheng
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.